Trial Profile
A study to evaluate the effect of irbesartan on uric acid levels and oxidative stress in patients with high risk hypertension
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2016
Price :
$35
*
At a glance
- Drugs Irbesartan (Primary)
- Indications Hypertension
- Focus Pharmacodynamics
- 07 Nov 2016 New trial record